Impact of TGFβ1 gene polymorphisms on acute and chronic rejection in pediatric heart transplant allografts

Transplantation

Volumn 81, Issue 6, 2006, Pages 934-939

  Di Filippo, Sylvie ^a,b   Zeevi, Adriana ^a   McDade, Kevin K ^a   Bastien, Olivier ^b   Webber, Steven A ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b LOUIS PRADEL HOSPITAL   (France)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Cardiac graft coronary disease; Gene polymorphisms; Interleukine 10; Pediatric heart transplantation; Transforming growth factor 1

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TRANSFORMING GROWTH FACTOR BETA1; TSUKUBAENOLIDE; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRAFT REJECTION; ARTICLE; CARDIAC GRAFT REJECTION; CHILD; CHRONIC GRAFT REJECTION; CODON; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ADOLESCENT; ALLOTRANSPLANTATION; GENETIC POLYMORPHISM; GENETICS; GRAFT REJECTION; IMMUNOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS;

EID: 33645637027     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000202725.55923.37     Document Type: Article

References (31)

1. Boucek MM, Edwards LB, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: sixth official pediatric report-2003. J Heart Lung Transplant 2003; 22: 636.
2. Pahl E, Naftel DC, Kuhn MA, et al. The impact and outcome of transplant coronary artery disease in a pediatric population: A 9-year multi-institutional study. J Heart Lung Transplant 2005; 24: 645.
3. Tejani A, Ping-Leung H, Emmett L, Stablein DM. Reduction in acute rejections decreases chronic rejection graft failure in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Transplant 2002; 2: 142.
4. Awad MR, Webber S, Boyle G, et al. The effect on cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 2001; 20: 625.
5. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV. Genotyping for polymorphisms in interferon-γ, interleukine-10, transforming growth factor-β1 and tumor necrosis factor-α genes: a technical report. Transplant Immunol 1998; 6: 193.
6. Hoffman SC, Stanley EM, Darin Cox E, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002; 2: 560.
7. Border WA, Noble NA. Transforming Growth Factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286.
8. Bijlsma FJ, van der Horst AA, Tilanus MG, et al. No association between transforming growth factor-beta gene polymorphism and acute allograft rejection after cardiac transplantation. Transpl Immunol 2002; 10: 43.
9. De Groot-Kruseman HA, Baan CC, Mol WM, et al. Upregulated transforming growth factor-β1 mRNA expression in endomyocardial biopsies during the development of graft vascular disease after clinical heart transplantation. Transplant Proc 1999; 31: 2724.
10. Häyry P. Chronic rejection: new potential venues on therapy. Transplant Proc 1999; 31: 1799.
11. Weis M, Von Scheidt W. Coronary artery disease in the transplanted heart. Annu Rev Med 2000; 51: 81.
12. Syrris P, Carter ND, Metcalfe JC, et al. Transforming growth factor-β1 gene polymorphisms and coronary artery disease. Clinical Science 1998; 95: 659.
13. Sun W, Wang Q, Zhang L, et al. TGFβ1 gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo. J Mol Med 2002; 80: 514.
14. Fischbein MP, Yun J, Laks H, et al. Regulated interleukine-10 expression prevents chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg 2003; 126: 216.
15. Boehler A. The role of interleukine-10 in lung transplantation. Transpl Immunol 2002; 9: 121.
16. Boehler A, Chamberlain D, Xing Z, et al. Adenovirus-mediated interleukine-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans. Hum Gene Ther 1998; 9: 541.
17. Aris RM, Walsh S, Chalermskulrat W, et al. Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med 2002; 166: 417.
18. Shittu EA, Yang CP, Roberts IS, et al. Inhibition of chronic vascular rejection by donor-specific blood transfusion is associated with a reduction in transforming growth factor-β1 expression. Transplantation 2002; 73: 1573.
19. Aziz T, Saad RA, Burgess M, et al. Transforming growth factor-beta and myocardial dysfunction following heart transplantation. Eur J Cardiothor Surg 2001; 20: 177.
20. Aziz T, Burgess M, Yonan N, et al. Transforming growth factor-beta and diastolic left ventricular dysfunction after heart transplantation: echographic and histological evidence. J Heart Lung Transplant 2003; 22: 663.
21. De Groot-Kuseman HA, Baan CC, Hagman EM, et al. Sequential monitoring of intragraft cytokine m RNA expression in relation to diastolic left ventricular wall thickness and function early after heart transplantation. Clin Transplant 2002; 16: 433.
22. Aziz T, Hasleton P, Hann AW, et al. Transforming growth factor-beta in relation to cardiac allograft vasculopathy after heart transplantation. J Thor Cardiovasc Surg 2000; 119: 700.
23. El-Gamel A, Awad M, Sim E, et al. Transforming growth factor-β1 and lung allograft fibrosis. Eur J Cardiothor Surg 1998; 13: 424.
24. El-Gamel A, Sim E, Hasleton P, et al. Transforming growth factor-beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999; 18: 828.
25. El-Gamel A, Awad MR, Hasleton PS, et al. Transforming growth factor-beta (TGFβ1) and lung allograft fibrosis. J Heart Lung Transplant 1999; 18: 517.
26. Guo Z, Binswanger U, Knoflach A. Role of codon 10 and codon 25 polymorphisms on TGF-β1 gene expression and protein synthesis in stable allograft recipients. Transplant Proc 2002; 34: 2904.
27. Densem CG, Hutchinson IV, Cooper A, et al. Polymorphisms of the Transforming growth factor-beta1 gene correlate with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 2000; 19: 551.
28. Holweg CT, Baan CC, Balk AH, et al. The transforming growth factor-beta1 codon 10 gene polymorphim and accelerated graft vascular disease after clinical heart transplantation. Transplantation 2001; 71: 1463.
29. Holweg CT, Weimar W, Uitterlinden AG, Baan CC. Clinical Impact of Cytokine Gene Polymorphisms in Heart and Lung Transplantation. J Heart Lung Transplant 2004; 23: 1017.
30. Densem CG, Ray M, Hutchinson IV, et al. Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy? J Heart Lung Transplant 2005; 24: 559.
31. Densem CG, Hutchinson IV, Yonan N, Brooks NH. Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease. Transpl Immunol 2004; 13: 211.